PMID- 16166739 OWN - NLM STAT- MEDLINE DCOM- 20060110 LR - 20171116 IS - 1044-1549 (Print) IS - 1044-1549 (Linking) VI - 33 IP - 6 DP - 2005 Dec TI - Involvement of discoidin domain receptor 1 in the deterioration of pulmonary sarcoidosis. PG - 565-73 AB - The prognosis of sarcoidosis with pulmonary infiltrates differs in each case, and several cytokines are reported to contribute to its deterioration. However, the detailed mechanism has not been fully elucidated. Discoidin domain receptor 1 (DDR1) is a receptor tyrosine kinase activated by collagen and associated with cytokine production from inflammatory cells. We previously reported the functional expression of DDR1 on CD14-positive bronchoalveolar lavage fluid (BALF) cells in vivo. In this study, we hypothesized that DDR1 might be associated with the deterioration of pulmonary sarcoidosis (PS), and investigated 33 patients with sarcoidosis with pulmonary infiltrates, prospectively. We found that patients with deteriorated PS showed significantly higher DDR1 expression in CD14-positive BALF cells predominant with DDR1b isoforms. Activation of DDR1 induced monocyte chemoattractant protein-1 (MCP-1) and matrix metalloproteinase-9 (MMP-9) production in a p38 mitogen-activated protein kinase-dependent manner from CD14-positive BALF cells of patients with deteriorated sarcoidosis. DDR1 activation also induced NF-kappaB nuclear translocation in CD14-positive BALF cells of patients with deteriorated PS. The inhibitor of NF-kappaB inhibited the production of MCP-1 and MMP-9. We propose that DDR1 is associated with the deterioration of pulmonary sarcoidosis. FAU - Matsuyama, Wataru AU - Matsuyama W AD - Division of Respiratory Medicine, Respiratory and Stress Care Center, Kagoshima University Hospital, Sakuragaoka 8-35-1, Kagoshima 890-8520, Japan. vega@xa2.so-net.ne.jp FAU - Mitsuyama, Hideo AU - Mitsuyama H FAU - Watanabe, Masaki AU - Watanabe M FAU - Shirahama, Yuko AU - Shirahama Y FAU - Higashimoto, Ikkou AU - Higashimoto I FAU - Osame, Mitsuhiro AU - Osame M FAU - Arimura, Kimiyoshi AU - Arimura K LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Retracted Publication DEP - 20050915 PL - United States TA - Am J Respir Cell Mol Biol JT - American journal of respiratory cell and molecular biology JID - 8917225 RN - 0 (Antibodies, Monoclonal) RN - 0 (Chemokine CCL2) RN - 0 (Lipopolysaccharide Receptors) RN - 0 (NF-kappa B) RN - 0 (Protein Isoforms) RN - 0 (Receptors, Mitogen) RN - EC 2.7.10.1 (Discoidin Domain Receptors) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) SB - IM RIN - Shapiro SD. Am J Respir Cell Mol Biol. 2008 Sep;39(3):380. PMID: 18695263 MH - Antibodies, Monoclonal/pharmacology MH - Bronchoalveolar Lavage Fluid/cytology MH - Case-Control Studies MH - Cell Nucleus/metabolism MH - Chemokine CCL2/metabolism MH - Discoidin Domain Receptors MH - Enzyme-Linked Immunosorbent Assay MH - Female MH - Humans MH - Lipopolysaccharide Receptors/metabolism MH - Male MH - Matrix Metalloproteinase 9/metabolism MH - Middle Aged MH - NF-kappa B/metabolism MH - Phosphorylation MH - Prospective Studies MH - Protein Isoforms MH - Protein Transport MH - Receptor Protein-Tyrosine Kinases/immunology/*metabolism MH - Receptors, Mitogen/agonists/immunology/*metabolism MH - Sarcoidosis, Pulmonary/*metabolism/pathology MH - Up-Regulation MH - p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors/metabolism EDAT- 2005/09/17 09:00 MHDA- 2006/01/13 09:00 CRDT- 2005/09/17 09:00 PHST- 2005/09/17 09:00 [pubmed] PHST- 2006/01/13 09:00 [medline] PHST- 2005/09/17 09:00 [entrez] AID - 2005-0236OC [pii] AID - 10.1165/rcmb.2005-0236OC [doi] PST - ppublish SO - Am J Respir Cell Mol Biol. 2005 Dec;33(6):565-73. doi: 10.1165/rcmb.2005-0236OC. Epub 2005 Sep 15.